Goto M - Search Results

1

Tacrolimus therapy according to mucosal MDR1 levels in small-bowel transplant recipients.

Masuda S, Uemoto S, Goto M, Fujimoto Y, Tanaka K, Inui K. Masuda S, et al. Among authors: goto m. Clin Pharmacol Ther. 2004 Apr;75(4):352-61. doi: 10.1016/j.clpt.2003.11.374. Clin Pharmacol Ther. 2004. PMID: 15060513

2

C3435T polymorphism in the MDR1 gene affects the enterocyte expression level of CYP3A4 rather than Pgp in recipients of living-donor liver transplantation.

Goto M, Masuda S, Saito H, Uemoto S, Kiuchi T, Tanaka K, Inui K. Goto M, et al. Pharmacogenetics. 2002 Aug;12(6):451-7. doi: 10.1097/00008571-200208000-00005. Pharmacogenetics. 2002. PMID: 12172213

3

Decreased expression of P-glycoprotein during differentiation in the human intestinal cell line Caco-2.

Goto M, Masuda S, Saito H, Inui K. Goto M, et al. Biochem Pharmacol. 2003 Jul 1;66(1):163-70. doi: 10.1016/s0006-2952(03)00242-9. Biochem Pharmacol. 2003. PMID: 12818377

4

Enhanced expression of enterocyte P-glycoprotein depresses cyclosporine bioavailability in a recipient of living donor liver transplantation.

Masuda S, Goto M, Kiuchi T, Uemoto S, Kodawara T, Saito H, Tanaka K, Inui K. Masuda S, et al. Among authors: goto m. Liver Transpl. 2003 Oct;9(10):1108-13. doi: 10.1053/jlts.2003.50179. Liver Transpl. 2003. PMID: 14526408 Free article.

5

CYP3A5*1-carrying graft liver reduces the concentration/oral dose ratio of tacrolimus in recipients of living-donor liver transplantation.

Goto M, Masuda S, Kiuchi T, Ogura Y, Oike F, Okuda M, Tanaka K, Inui K. Goto M, et al. Pharmacogenetics. 2004 Jul;14(7):471-8. doi: 10.1097/01.fpc.0000114747.08559.49. Pharmacogenetics. 2004. PMID: 15226679

6

Transient up-regulation of P-glycoprotein reduces tacrolimus absorption after ischemia-reperfusion injury in rat ileum.

Omae T, Goto M, Shimomura M, Masuda S, Ito K, Okuda M, Inui K. Omae T, et al. Among authors: goto m. Biochem Pharmacol. 2005 Feb 15;69(4):561-8. doi: 10.1016/j.bcp.2004.10.016. Epub 2004 Dec 25. Biochem Pharmacol. 2005. PMID: 15670575

7

Intestinal MDR1/ABCB1 level at surgery as a risk factor of acute cellular rejection in living-donor liver transplant patients.

Masuda S, Goto M, Fukatsu S, Uesugi M, Ogura Y, Oike F, Kiuchi T, Takada Y, Tanaka K, Inui K. Masuda S, et al. Among authors: goto m. Clin Pharmacol Ther. 2006 Jan;79(1):90-102. doi: 10.1016/j.clpt.2005.09.013. Clin Pharmacol Ther. 2006. PMID: 16413244

8

Population pharmacokinetic and pharmacogenomic analysis of tacrolimus in pediatric living-donor liver transplant recipients.

Fukudo M, Yano I, Masuda S, Goto M, Uesugi M, Katsura T, Ogura Y, Oike F, Takada Y, Egawa H, Uemoto S, Inui K. Fukudo M, et al. Among authors: goto m. Clin Pharmacol Ther. 2006 Oct;80(4):331-45. doi: 10.1016/j.clpt.2006.06.008. Clin Pharmacol Ther. 2006. PMID: 17015051

9

Relation between mRNA expression level of multidrug resistance 1/ABCB1 in blood cells and required level of tacrolimus in pediatric living-donor liver transplantation.

Goto M, Masuda S, Kiuchi T, Ogura Y, Oike F, Tanaka K, Uemoto S, Inui K. Goto M, et al. J Pharmacol Exp Ther. 2008 May;325(2):610-6. doi: 10.1124/jpet.107.135665. Epub 2008 Feb 5. J Pharmacol Exp Ther. 2008. PMID: 18252812 Clinical Trial.

10

Required transient dose escalation of tacrolimus in living-donor liver transplant recipients with high concentrations of a minor metabolite M-II in bile.

Shimomura M, Masuda S, Goto M, Katsura T, Kiuchi T, Ogura Y, Oike F, Takada Y, Uemoto S, Inui K. Shimomura M, et al. Among authors: goto m. Drug Metab Pharmacokinet. 2008;23(5):313-7. doi: 10.2133/dmpk.23.313. Drug Metab Pharmacokinet. 2008. PMID: 18974608 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,191 results

Search Page

Filters